The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Sanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00074.x · Cited by 556
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Rao, G. N., Corson, M. A., & Berk, B. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93017-6 · Cited by 391
ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.691 · Cited by 386
Kanbay, M., Ozkara, A., Selcoki, Y., Isik, B., Turgut, F., Bavbek, N., Uz, E., Akcay, A., Yigitoglu, R., & Covic, A. (2007) · International Urology and Nephrology · doi:10.1007/s11255-007-9253-3 · Cited by 325
Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc11-1346 · Cited by 274
Hyperuricemia Causes Glomerular Hypertrophy in the Rat
Nakagawa, T., Mazzali, M., Kang, D.-H., Kanellis, J., Watanabe, S., Sanchez-Lozada, L. G., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Johnson, R. J. (2003) · American Journal of Nephrology · doi:10.1159/000066303 · Cited by 269
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Kosugi, T., Nakayama, T., Heinig, M., Zhang, L., Yuzawa, Y., Sanchez-Lozada, L. G., Roncal, C., Johnson, R. J., & Nakagawa, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2009 · Cited by 172
Kushiyama, A., Okubo, H., Sakoda, H., Kikuchi, T., Fujishiro, M., Sato, H., Kushiyama, S., Iwashita, M., Nishimura, F., Fukushima, T., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234559 · Cited by 130
Adenine-induced chronic kidney and cardiovascular damage in rats
Diwan, V., Mistry, A., Gobe, G. C., & Brown, L. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.05.006 · Cited by 128
Sánchez‐Lozada, L. G., Tapia, E., Soto, V., Ávila-Casado, C., Franco, M., Wessale, J. L., Zhao, L., & Johnson, R. J. (2008) · Nephron Physiology · doi:10.1159/000127837 · Cited by 107
Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
Choukroun, G. J., Itakura, Y., Albouze, G., Christophe, J. L., Man, N. K., Grünfeld, J., & Jungers, P. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v661634 · Cited by 88
AkifumiKushiyama, HirofumiOkubo, HideyukiSakoda, TakakoKikuchi, MidoriFujishiro, HirokazuSato, SakuraKushiyama, MisakiIwashita, FusanoriNishimura, ToshiakiFukushima, et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · Cited by 79
Preservation of Renal Function during Gout Treatment with Febuxostat: A Quantitative Study
Whelton, A., MacDonald, P. A., Chefo, S., & Gunawardhana, L. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.01.2626 · Cited by 60
The Association between Uric Acid and Chronic Kidney Disease in Korean Men: A 4-Year Follow-up Study
Ryoo, J., Choi, J., Oh, C., & Kim, M. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.6.855 · Cited by 51
Uric Acid Levels and All-Cause Mortality in Peritoneal Dialysis Patients
Feng, S., Jiang, L., Shi, Y., Shen, H., Shi, X., Jin, D., Zeng, Y., & Wang, Z. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000350143 · Cited by 51
Iseki, K., Iseki, C., & Kinjo, K. (2013) · Hypertension Research · doi:10.1038/hr.2013.11 · Cited by 51
Chang, H., Lee, P., Lei, C., Tung, C., Hsu, Y., Huang, T., Lu, L.-C., & Lin, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061450 · Cited by 42
Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout
Saag (2009) · Core evidence · doi:10.2147/ce.s5999 · Cited by 26
Hyperuricemia Is an Independent Risk Factor for Mortality Only if Chronic Kidney Disease Is Present
Chung, W., Kim, A. J., Ro, H., Chang, J. H., Lee, H. H., & Jung, J. Y. (2013) · American Journal of Nephrology · doi:10.1159/000350534 · Cited by 17
Maeda, K., Hamada, C., Horikoshi, S., et al. (2012) · ISRN Nephrology · doi:10.5402/2013/351364 · Cited by 2
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Johnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
Metadata
- Authors
- Sircar, D., Chatterjee, S., Waikhom, R., Golay, V., Raychaudhury, A., Chatterjee, S., & Pandey, R.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 66
- Issue
- 6
- Pages
- 945-950
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W1499216809
- Cited by
- 314
- References
- 24
- FWCI
- 29.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.